Difference between revisions of "Team:ETH Zurich/Achievements"
Line 28: | Line 28: | ||
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Genetic_circuit">genetic circuit</a> that integrates two different cancer specific signals (<a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">lactate </a>and <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module">AHL</a>)in an <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Combined_Model#Combined_Model">AND gate</a>.</li> | <li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Genetic_circuit">genetic circuit</a> that integrates two different cancer specific signals (<a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">lactate </a>and <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module">AHL</a>)in an <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Combined_Model#Combined_Model">AND gate</a>.</li> | ||
− | <li>We | + | <li>We implemented a method to do single cell analysis of cancer cells by <a href="https://2015.igem.org/Team:ETH_Zurich/Design#System_Overview">expressing Annexin V on the <i>E. coli</i> membrane</a> that makes them stick to apoptotic mammalian cells.</li></ul> |
<p></p> | <p></p> | ||
Line 36: | Line 36: | ||
<ul><li>We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a very limited amount of information present in the literature.</li> | <ul><li>We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a very limited amount of information present in the literature.</li> | ||
− | <li>We | + | <li>We design x synthetic lldR dependent promoters and characterized them (additionally the influence of the lacate importer llDP was characterized)</li> |
<li>We documented and submitted XX new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with XX parts.</li> | <li>We documented and submitted XX new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with XX parts.</li> | ||
− | <li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for later easy application of our MicroBeacon E. coli.</li> | + | <li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for later easy application of our MicroBeacon <i>E. coli</i>.</li> |
<li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li> | <li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li> | ||
Line 55: | Line 55: | ||
<h3>Human Practices Achievements</h3> | <h3>Human Practices Achievements</h3> | ||
− | <ul><li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Stockholm">collaborated</a>with the team from <a href="https://2015.igem.org/Team:Stockholm"> Stockholm</a> by testing some of their constructs.</li> | + | <ul><li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Stockholm">collaborated</a> with the team from <a href="https://2015.igem.org/Team:Stockholm"> Stockholm</a> by testing some of their constructs.</li> |
<li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Amoy">contributed</a> to the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">Newsletters</a> from <a href="https://2015.igem.org/Team:Amoy#">Amoys team</a>, met with the <a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt team</a>, helped with a survey from <a href="https://2015.igem.org/Team:EPF_Lausanne">EPFL</a> and provided <a href="https://2015.igem.org/Team:Uniandes_Colombia">Colombias team</a> with protocols and <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Colombia">advice</a> when their transformations did not work.</li> | <li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Amoy">contributed</a> to the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">Newsletters</a> from <a href="https://2015.igem.org/Team:Amoy#">Amoys team</a>, met with the <a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt team</a>, helped with a survey from <a href="https://2015.igem.org/Team:EPF_Lausanne">EPFL</a> and provided <a href="https://2015.igem.org/Team:Uniandes_Colombia">Colombias team</a> with protocols and <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Colombia">advice</a> when their transformations did not work.</li> |
Revision as of 09:50, 14 September 2015
- Project
- Modeling
- Lab
- Human
Practices - Parts
- About Us
Achievements
We are proud to announce that we achieved the following goals
General Achievements
- We designed a novel system for detection of circulating tumour cells in blood samples using genetically modified bacteria.
- We designed a genetic circuit that integrates two different cancer specific signals (lactate and AHL)in an AND gate.
- We implemented a method to do single cell analysis of cancer cells by expressing Annexin V on the E. coli membrane that makes them stick to apoptotic mammalian cells.
Experimental Achievements
- We characterized parts of the natural E. coli lldPRD-operon, on which there is only a very limited amount of information present in the literature.
- We design x synthetic lldR dependent promoters and characterized them (additionally the influence of the lacate importer llDP was characterized)
- We documented and submitted XX new basic parts to the iGEM parts registry and created a part collection with XX parts.
- We designed a chip for later easy application of our MicroBeacon E. coli.
- We participated in the interlab study.
- We attended the safety instrucions from the department D-BSSE in basel where we have our lab.
Modeling Achievements
- By modeling the system we showed that the system as a whole can work.
Human Practices Achievements
- We collaborated with the team from Stockholm by testing some of their constructs.
- We contributed to the Newsletters from Amoys team, met with the Darmstadt team, helped with a survey from EPFL and provided Colombias team with protocols and advice when their transformations did not work.
- We interviewed many different experts from various fields, such as medical doctors, somebody from the ethics commission, the founder of a start-up or an expert in patents law and integrated the advice and ideas we got from them into the design.
- We went to two different schools, thaught the children about what DNA is, performed experiments with them and published an article about it in the local newspaper.
- We told the ETH-student magacine polykum about iGEM and gave an interview.